Items where Author is "Ng, C. K. Y."
Jump to: 21 December 2021 | 2018 Number of items: 3. 21 December 2021Suter, P. and Dazert, E. and Kuipers, J. and Ng, C. K. Y. and Boldanova, T. and Hall , M. N. and Heim, M. H. and Beerenwinkel, N.. (2021) Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model. 2018Piscuoglio, S. and Ng, C. K. Y. and Weigelt, B. and Chandarlapaty, S. and Reis-Filho, J. S.. (2018) ESR1 and endocrine therapy resistance: more than just mutations. Annals of oncology, 29 (4). pp. 787-789. Ng, C. K. Y. and Di Costanzo, G. G. and Tosti, N. and Paradiso, V. and Coto-Llerena, M. and Roscigno, G. and Perrina, V. and Quintavalle, C. and Boldanova, T. and Wieland, S. and Marino-Marsilia, G. and Lanzafame, M. and Quagliata, L. and Condorelli, G. and Matter, M. S. and Tortora, R. and Heim, M. H. and Terracciano, L. M. and Piscuoglio, S.. (2018) Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study. Annals of Oncology, 29 (5). pp. 1286-1291. |
